Fairvalue-Calculator Fairvalue-Calculator
EN DE

NEXE Innovations Inc (NEXE) Fair Value & Analysis

Consumer Cyclical · CA · Market cap C$14.1M

PriceC$0.1450
Fair ValueC$0.1300
Upside-10.3%
Quality92/100
Evidence: Low Range C$0.0900 – C$0.1600

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

NEXE Innovations Inc (NEXE) currently trades at C$0.1450, while our model-based Fair Value estimate is C$0.1300 — implying the stock looks roughly 10.3% overvalued today. We read business quality at 92/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

NEXE Innovations Inc. manufactures and sells plant-based single-serve coffee pods for use in single-serve coffee machines in Canada. NEXE Innovations Inc. was founded in 2015 and is headquartered in Surrey, Canada.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is NEXE Innovations Inc (NEXE) undervalued?
As of Jun 26, 2026, our model estimates a fair value of C$0.1300 versus a price of C$0.1450 — about −10% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NEXE?
Our 21-model fair value for NEXE Innovations Inc is C$0.1300 (as of Jun 26, 2026), built from audited fundamentals. The current price is C$0.1450.
What is the quality score of NEXE?
NEXE Innovations Inc has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.